2024-01-01 2024-12-31 false Capium Accounts Production 1.1 08329686 2024-01-01 2024-12-31 08329686 bus:AbridgedAccounts 2024-01-01 2024-12-31 08329686 bus:Micro-entities 2024-01-01 2024-12-31 08329686 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 08329686 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 08329686 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 08329686 2024-01-01 2024-12-31 08329686 2024-12-31 08329686 bus:RegisteredOffice 2024-01-01 2024-12-31 08329686 core:WithinOneYear 2024-12-31 08329686 core:AfterOneYear 2024-12-31 08329686 1 2024-01-01 2024-12-31 08329686 bus:Director1 2024-01-01 2024-12-31 08329686 bus:Director1 2024-12-31 08329686 bus:Director1 2023-01-01 2023-12-31 08329686 2023-01-01 08329686 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 08329686 2023-01-01 2023-12-31 08329686 2023-12-31 08329686 core:WithinOneYear 2023-12-31 08329686 core:AfterOneYear 2023-12-31 08329686 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 08329686 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 08329686 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 08329686 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 08329686 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 08329686 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 08329686 core:Non-currentFinancialInstruments 2024-12-31 08329686 core:Non-currentFinancialInstruments 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 08329686
England and Wales

 

 

 

CRYSTAL BIOTECK SOLUTIONS LTD.



Abridged Accounts
 


Period of accounts

Start date: 01 January 2024

End date: 31 December 2024
  2024   2023
    £ £   £ £
Current assets (2,803)     (1,745)  
Creditors: amount falling due within one year (5,086)      
Net current assets   (7,889)     (1,745)
Total assets less current liabilities   (7,889)     (1,745)
Creditors: amount falling due after more than one year   (8,332)     (12,151)
Net assets   (16,221)     (13,896)
 

         
Capital and reserves   (16,221)     (13,896)
 
NOTES TO THE ACCOUNTS

General Information
CRYSTAL BIOTECK SOLUTIONS LTD. is a private company, limited by shares, registered in England and Wales, registration number 08329686, registration address Suite 5802 Unite 3a, 34-35 Hatton Garden, Holborn, London, EC1N 8DX.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 1 (2023 : 2).


For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the director on 14 September 2025 and were signed by:


--------------------------------
Devashish BHARAJ
Director
1